Literature DB >> 22434932

The structure of the TLR5-flagellin complex: a new mode of pathogen detection, conserved receptor dimerization for signaling.

Jinghua Lu1, Peter D Sun.   

Abstract

Knowledge about how Toll-like receptors (TLRs) recognize pathogenic ligands is critical to understanding how these receptors are activated and to designing therapeutic compounds that target this family of receptors for inflammatory diseases. The crystal structure of TLR5 in complex with its bacterial ligand flagellin revealed that the ligand-binding mode for TLR5 is distinct from that of previously characterized TLRs. Nevertheless, like other TLRs, TLR5 forms a dimer in response to ligand binding. This work contributes to our current knowledge of TLR function and further demonstrates the ability of TLRs to couple versatile ligand recognition to a conserved receptor signaling mechanism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22434932     DOI: 10.1126/scisignal.2002963

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  16 in total

Review 1.  Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K.

Authors:  Ty Dale Troutman; J Fernando Bazan; Chandrashekhar Pasare
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

Review 2.  Trial Watch: Toll-like receptor agonists in cancer immunotherapy.

Authors:  Melody Smith; Elena García-Martínez; Michael R Pitter; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-10-11       Impact factor: 8.110

Review 3.  Mapping FLS2 function to structure: LRRs, kinase and its working bits.

Authors:  Silke Robatzek; Lennart Wirthmueller
Journal:  Protoplasma       Date:  2012-10-05       Impact factor: 3.356

4.  Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes.

Authors:  Kirill Kalnin; Timothy Tibbitts; Yanhua Yan; Svetlana Stegalkina; Lihua Shen; Victor Costa; Robert Sabharwal; Stephen F Anderson; Patricia M Day; Neil Christensen; John T Schiller; Subhashini Jagu; Richard B S Roden; Jeffrey Almond; Harold Kleanthous
Journal:  Vaccine       Date:  2014-04-26       Impact factor: 3.641

Review 5.  Trafficking of endosomal Toll-like receptors.

Authors:  Bettina L Lee; Gregory M Barton
Journal:  Trends Cell Biol       Date:  2014-01-15       Impact factor: 20.808

6.  Adaptive evolution of Toll-like receptor 5 in domesticated mammals.

Authors:  Sarah A Smith; Oliver C Jann; David Haig; George C Russell; Dirk Werling; Elizabeth J Glass; Richard D Emes
Journal:  BMC Evol Biol       Date:  2012-07-24       Impact factor: 3.260

7.  Epithelial uptake of flagella initiates proinflammatory signaling.

Authors:  Dane Parker; Alice Prince
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

Review 8.  Trial Watch: Toll-like receptor agonists for cancer therapy.

Authors:  Erika Vacchelli; Alexander Eggermont; Catherine Sautès-Fridman; Jérôme Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-06-10       Impact factor: 8.110

9.  Functional characterisation of bovine TLR5 indicates species-specific recognition of flagellin.

Authors:  Hannah J Metcalfe; Roberto M La Ragione; David G E Smith; Dirk Werling
Journal:  Vet Immunol Immunopathol       Date:  2013-12-30       Impact factor: 2.046

10.  Trial Watch: Toll-like receptor agonists in oncological indications.

Authors:  Fernando Aranda; Erika Vacchelli; Florine Obrist; Alexander Eggermont; Jérôme Galon; Catherine Sautès-Fridman; Isabelle Cremer; Jan Henrik Ter Meulen; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-08-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.